• 1. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761
• 2. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

Introduction to [4-Methyl-5-(tert-butyl)-d12]-pyridine-3-boronic acid (CAS No. 2225174-00-3)

[4-Methyl-5-(tert-butyl)-d12]-pyridine-3-boronic acid (CAS No. 2225174-00-3) is a specialized boronic acid derivative that has garnered significant attention in the fields of organic synthesis and medicinal chemistry. This compound is characterized by its unique structural features, including a substituted pyridine ring and a boronic acid functional group, which make it a valuable reagent in various chemical reactions and biological applications.

The pyridine ring, a six-membered aromatic heterocycle containing one nitrogen atom, is a fundamental building block in many pharmaceuticals and agrochemicals. The presence of the boronic acid group in [4-Methyl-5-(tert-butyl)-d12]-pyridine-3-boronic acid imparts unique reactivity and functional versatility, making it an essential component in Suzuki-Miyaura coupling reactions, which are widely used for the formation of carbon-carbon bonds in the synthesis of complex organic molecules.

Recent research has highlighted the potential of boronic acids, including [4-Methyl-5-(tert-butyl)-d12]-pyridine-3-boronic acid, in the development of novel therapeutic agents. For instance, studies have shown that boronic acids can act as inhibitors of various enzymes, such as proteases and kinases, which are implicated in numerous diseases. The tert-butyl and methyl substituents on the pyridine ring enhance the compound's stability and solubility, making it more suitable for biological applications.

In the context of medicinal chemistry, [4-Methyl-5-(tert-butyl)-d12]-pyridine-3-boronic acid has been explored for its potential as a prodrug precursor. Prodrugs are biologically inactive compounds that are converted into active drugs within the body through metabolic processes. The boronic acid group can be designed to undergo specific transformations under physiological conditions, releasing active therapeutic agents with improved pharmacokinetic properties.

The deuterated nature of the compound, indicated by the d12 label, further enhances its utility in drug development. Deuterium substitution can lead to increased metabolic stability and reduced toxicity, which are crucial factors in the design of safe and effective medications. This feature makes [4-Methyl-5-(tert-butyl)-d12]-pyridine-3-boronic acid particularly attractive for use in preclinical and clinical studies.

From a synthetic perspective, the preparation of [4-Methyl-5-(tert-butyl)-d12]-pyridine-3-boronic acid involves several well-established chemical transformations. The synthesis typically begins with the formation of a substituted pyridine derivative, followed by the introduction of the boronic acid group through a suitable boronation reaction. The deuterium labeling is achieved through selective deuteration steps, ensuring high purity and isotopic enrichment.

The physical properties of [4-Methyl-5-(tert-butyl)-d12]-pyridine-3-boronic acid, such as its melting point, solubility, and stability under various conditions, have been extensively characterized. These properties are crucial for optimizing its use in both laboratory-scale experiments and large-scale manufacturing processes. Additionally, safety data sheets (SDS) provide important information on handling and storage to ensure safe use in research settings.

In conclusion, [4-Methyl-5-(tert-butyl)-d12]-pyridine-3-boronic acid (CAS No. 2225174-00-3) is a versatile compound with significant potential in organic synthesis and medicinal chemistry. Its unique structural features and functional groups make it an invaluable tool for researchers working on new drug discovery and development projects. As ongoing research continues to uncover new applications for this compound, it is expected to play an increasingly important role in advancing scientific knowledge and improving human health.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)